| Literature DB >> 29562591 |
Marit K Zinöcker1, Inge A Lindseth2.
Abstract
The dietary pattern that characterizes the Western diet is strongly associated with obesity and related metabolic diseases, but biological mechanisms supporting these associations remain largely unknown. We argue that the Western diet promotes inflammation that arises from both structural and behavioral changes in the resident microbiome. The environment created in the gut by ultra-processed foods, a hallmark of the Western diet, is an evolutionarily unique selection ground for microbes that can promote diverse forms of inflammatory disease. Recognizing the importance of the microbiome in the development of diet-related disease has implications for future research, public dietary advice as well as food production practices. Research into food patterns suggests that whole foods are a common denominator of diets associated with a low level of diet-related disease. Hence, by studying how ultra-processing changes the properties of whole foods and how these foods affect the gut microbiome, more useful dietary guidelines can be made. Innovations in food production should be focusing on enabling health in the super-organism of man and microbe, and stronger regulation of potentially hazardous components of food products is warranted.Entities:
Keywords: acellular nutrients; additives; dietary guidelines; food industry; inflammation; metabolic disease; microbiome; ultra-processed food; western diet; whole foods
Mesh:
Substances:
Year: 2018 PMID: 29562591 PMCID: PMC5872783 DOI: 10.3390/nu10030365
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717
Components of a Western diet and effects on the microbiota and/or host physiology. This is not an exhaustive list. Examples are chosen based on a crude assessment of relevance to issues discussed in this paper (dosages administered are below or correspond to ADI levels, or are meant to mimic estimated intake levels in humans).
| Food Additives | Effect on Microbiota | Effect on Host Physiology | Organism/Treatment | Reference |
|---|---|---|---|---|
| CMC | Bacterial overgrowth | Intestinal inflammation | Mice (IL10−/−). 2% CMC, 3 weeks | [ |
| CMC, P-80 | Microbiota encroachment, altered species composition, increased pro-inflammatory potential | Colitis, metabolic syndrome | Mice (IL10−/−, TLR5−/−). 1% CMC/P-80, 12 weeks | [ |
| CMC, P-80 | Increased pro-inflammatory potential | Human colon model. 1% CMC/P-80, duration: n/a | [ | |
| P-80 | Microbiota encroachment, altered species composition, increased pro-inflammatory potential | Intestinal inflammation, obesity, liver dysfunction | Mice (WT). 1% P-80 per kg. bw, 4 weeks | [ |
| GML | Gut microbiota dysbiosis | Metabolic syndrome, systemic low-grade inflammation | Mice (WT). 150 mg·kg−1 GML, 8 weeks | [ |
| Titanium dioxide | Decrease in absorptive microvilli, decreased nutrient uptake | Human colon cells. 2.3 × 109 (high), 2.3 × 107 (medium), 2.3 × 105 (low) particles/mL | [ | |
| Sucralose | Increased expression of bacterial pro-inflammatory mediators | Elevated pro-inflammatory gene expression in the liver | Mice (WT). 0.1 mg/mL sucralose, 6 months | [ |
| NAS | Compositional and functional alterations of microbiota associated with obesity | Glucose intolerance | Mice (WT). 0.1 mg/mL−1 saccharin, 5 weeks | [ |
| Saccharin | Increased pro-inflammatory potential | Liver inflammation | Mice (WT). 0.3 mg/mL saccharin, 6 months | [ |
| Aspartame | Compositional alterations of microbiota | Glucose intolerance | Rats (WT). 5–7 mg/kg/d, 10 weeks | [ |
| Acesulfame K | Compositional and functional alterations of microbiota associated with obesity | Weight gain (male) | Mice (CD-1). 37.5 mg/kg/d, 4 weeks | [ |
| Silver nanoparticles | Gut microbial alterations associated with obesity and inflammatory diseases | Mice (WT). 46, 460 or 4600 ppb Ag NP, 28 days | [ |
Acceptable daily intake (ADI), Polysorbate 80 (P-80), Carboxymethylcellulose (CMC), Non-caloric artificial sweeteners (NAS), Glycerol Monolaureate (GML), Interleukin (IL), Toll like receptor (TLR), Wild type (WT), Not available (n/a), Body weight (bw), Cluster of differentiation 1 (CD1), Part per billion (ppb), Silver (Ag), Nanoparticles (NP).